Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.
Search News
Recent Posts
- Dr. David T. Rubin on the 100th Episode of Bowel Moments Podcast
- UChicago Medicine Patient First in the World to Receive Ulcerative Colitis Drug Since FDA Approval
- Dr. David T. Rubin on “How I Treat Ulcerative Colitis”
- Dr. David T. Rubin on Transabdominal Ultrasound for IBD: Lessons from STARDUST Substudy on Ustekinumab
- Dr. Noa Krugliak Cleveland Discusses Her Award-Winning Research on Decreasing Time to Treatment Change and Remission in IBD Patients
Archives
- October 2024
- September 2024
- April 2024
- January 2024
- October 2023
- August 2023
- June 2023
- April 2023
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- December 2020
- October 2020
- September 2020
- July 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- June 2019
- March 2019
- January 2019
- November 2018
- July 2018
- May 2018
- September 2017